US 11981741
Humanized anti-CD45 antibodies
granted A61KA61K51/1027A61K51/1069
Quick answer
US patent 11981741 (Humanized anti-CD45 antibodies) held by Actinium Phamaceuticals, Inc. expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Actinium Phamaceuticals, Inc.
- Grant date
- Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K51/1027, A61K51/1069, A61K51/1096